In MAPTP301S PS19 mouse model of tauopathy, clearance of p16INK4A-positive senescent astrocytes and microglia by using INK-ATTAC transgenic mice attenuates gliosis, tau hyperphosphorylation, and neurodegeneration [239]. Here, MAPT is linked to tauopathy.